Press release
Drug Discovery Services Market to Reach US$ 46.52 Billion by 2031, Growing at 14.8% CAGR
Drug Discovery Services Market
The global drug discovery services market was valued at US$ 15.58 billion in 2023 and is projected to reach US$ 46.52 billion by 2031, expanding at a CAGR of 14.8% (2024-2031), according to DataM Intelligence. Advances in AI-driven drug discovery, growing outsourcing trends, the shift toward personalized medicine, and rising incidences of chronic diseases are the key forces transforming this market landscape.
Pharmaceutical and biotechnology companies are significantly increasing R&D expenditures to accelerate timelines and improve success rates in early-stage drug discovery. High-throughput screening, computational chemistry, genomics, and bioinformatics tools have become critical in identifying, screening, and optimizing new therapeutics more efficiently than ever before.
Get a Free Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/drug-discovery-services-market?utm_source=OpenPR&utm_campaign=Onkar
Key Highlights from the Report
➤ Market to grow from US$ 15.58 billion (2023) to US$ 46.52 billion (2031) at 14.8% CAGR
➤ Computational chemistry segment leads with a 31.7% market share, driven by AI integration
➤ North America dominates with 38.6% market share due to strong R&D infrastructure and funding
➤ Growing outsourcing trend to CROs for speed, efficiency, and cost-effectiveness
➤ Rising focus on personalized medicine and targeted therapies
➤ AI and machine learning revolutionizing drug candidate identification and optimization
Market Segmentation
Based on process type, computational chemistry is set to maintain dominance, leveraging methods such as molecular docking, virtual screening, QSAR modeling, and molecular dynamics to rapidly identify and refine promising drug candidates. The integration of machine learning and quantum chemistry, as seen in collaborations like Bayer and Google Cloud, is further enhancing speed, accuracy, and predictive capacity.
By service type, offerings span target identification, hit-to-lead studies, lead optimization, and preclinical development, with strong uptake from pharmaceutical and biotech companies outsourcing early-stage studies to optimize resource usage and reduce overhead costs.
By application, oncology holds a significant share, given the escalating demand for novel cancer treatments, followed by infectious and neurological disease research.
Get Customization in the Report as Per Your Business Requirements: https://www.datamintelligence.com/customize/drug-discovery-services-market?utm_source=OpenPR&utm_campaign=Onkar
Regional Insights
North America leads the market, accounting for approximately 38.6% of global revenue, supported by advanced research ecosystems, robust funding, and an extensive clinical trial infrastructure. Collaborations between industry giants and CROs, such as Charles River Laboratories' partnership with SAMDI Tech for high-throughput screening services, are further strengthening the region's leadership.
Asia-Pacific is the fastest-growing region, driven by cost-effective research capabilities, expanding biotech sectors in China and India, and increasing government incentives for drug R&D. Rising investments in AI-based research platforms are enabling the region to close the innovation gap with developed markets.
Market Dynamics
Market Drivers
The rise in global chronic disease burden-especially cancer, cardiovascular, and neurological disorders-coupled with high R&D investments from pharma and biotech companies, has intensified demand for advanced drug discovery services.
Market Restraints
The high cost of drug discovery, averaging up to US$ 2.3 billion per approved drug, poses a barrier for small and mid-sized companies. Long development cycles, high attrition rates, and regulatory compliance costs further challenge market growth.
Market Opportunities
The growing integration of AI/ML platforms, the push toward universal and multifunctional drug candidates, and expanding partnerships between tech firms and pharma companies present lucrative growth opportunities in the coming decade.
Purchase This Exclusive Report at Just USD 4384 Only: https://www.datamintelligence.com/buy-now-page?report=drug-discovery-services-market?utm_source=OpenPR&utm_campaign=Onkar
Reasons to Buy the Report
✔ Comprehensive coverage of market size, growth drivers, and challenges
✔ Deep insights into technological innovations reshaping the drug discovery process
✔ Competitive benchmarking of leading CROs and service providers
✔ Regional analysis identifying investment hotspots and emerging markets
✔ Strategic recommendations for capturing high-growth segments within the market
Frequently Asked Questions (FAQs)
◆ How big is the global drug discovery services market in 2023?
◆ What are the main drivers of growth in the drug discovery services market?
◆ Who are the top players in the global drug discovery outsourcing industry?
◆ What CAGR is projected for the market during 2024-2031?
◆ Which region will dominate the drug discovery services market by 2031?
Company Insights
Piramal Pharma Solutions
Biopta
Charles River Laboratories International
Domainex
Evotec AG
Albany Molecular Research Inc.
GenScript
Pharmaceutical Product Development (PPD)
WuXi AppTec
Merck & Co., Inc.
Recent Developments:
May 2023 - Google Cloud launched AI-powered suites-Target and Lead Identification Suite & Multiomics Suite-to accelerate biotech drug discovery and precision medicine.
November 2022 - Sanofi entered a multi-year strategic AI collaboration with Insilico Medicine to accelerate discovery of up to six novel drug targets.
Conclusion
The global drug discovery services market is entering a transformative phase where AI, computational chemistry, and outsourcing models are redefining timelines, costs, and success rates in new drug development. While North America leads in capability and revenue share, Asia-Pacific is quickly emerging as a competitive hub with scalable, cost-effective solutions. Continuous innovation and collaboration across tech, biotech, and pharma will ensure sustained growth and scientific breakthroughs in the years to come.
Contact Us
Mr. Sai Kiran
DataM Intelligence 4market Research LLP Ground floor
DSL Abacus IT Park, Industrial Development Area
Uppal, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com
Visit Our Website: https://www.datamintelligence.com
About Us
DataM Intelligence 4Market Research is a comprehensive market intelligence platform offering syndicated and customized reports along with expert consulting across multiple industries, including chemicals, healthcare, agriculture, food & beverages, and more. With extensive experience and a strategy-focused approach, DataM provides businesses and individuals with reliable market insights, statistical forecasts, and personalized research solutions to help them make informed decisions and successfully bring innovations to market.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Drug Discovery Services Market to Reach US$ 46.52 Billion by 2031, Growing at 14.8% CAGR here
News-ID: 4211727 • Views: …
More Releases from DataM Intelligence 4Market Research LLP
Frozen Fruits Market Surges Toward US$6.54 Billion by 2030 - Asia-Pacific Leads …
According to DataM Intelligence, the global frozen fruits market size was valued at US$3,957.4 million in 2022 and is forecasted to reach US$6,549.4 million by 2030, growing at a CAGR of 6.5% from 2024 to 2031. This steady growth is propelled by rising health consciousness among consumers, increasing demand for convenient and nutritious food options, expanding food processing and service sectors, growing preference for organic and plant-based products, surging popularity…
United States Feed Testing Market Booms on 6.50% CAGR - North America Dominates …
According to DataM Intelligence, the global feed testing market size was valued at US$3.50 billion in 2024 and is forecasted to reach US$5.70 billion by 2031, growing at a CAGR of 6.50% during the forecast period (2024-2031). This steady growth is propelled by stringent regulatory standards for animal feed safety, rising demand for high-quality meat and dairy products, increasing livestock production, growing pet food safety concerns, and expanding focus on…
United States Sugar Decorations & Inclusions Market Surges on 5.80% CAGR - Custo …
According to DataM Intelligence, the global sugar decorations and inclusions market size was valued at US$2.15 billion in 2023 and is forecasted to reach US$3.45 billion by 2030, growing at a CAGR of 5.80% from 2023 to 2030. This steady growth is propelled by rising demand for personalized baked goods, expanding bakery and confectionery sectors, increasing consumer preference for visually appealing desserts, growth in organized retail for convenience foods, and…
Aluminum Extrusion Industry Forecast 2025-2031: Rising Demand in Automotive and …
Global Aluminum Extrusion Market reached US$ 78.7 billion in 2022 and is expected to reach US$ 117.8 billion by 2030, growing with a CAGR of 5.7% during the forecast period 2025-2031.
According to DataM Intelligence has published a new research report on "Aluminium Extrusion Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and…
More Releases for R&D
Sales Acceleration Technology Market 2023: Sales and Industry Revenue Forecasts- …
The Sales Acceleration Technology market has witnessed growth from USD XX million to USD XX million from 2017 to 2023. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2029.
The report focuses on the Sales Acceleration Technology market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides detailed cost analysis, supply chain.
Technological…
R&D Incentive Services Market is Booming Worldwide | KPMG, R&D Incentives, Deloi …
The latest report released on Global R&D Incentive Services Market analyses areas where there is still room for improvement. Irrespective of industry, organization size, or geographic location, the R&D Incentive Services Market study suggests that advanced technologies are playing a bigger role than ever before. The assessment provides trend, growth factors and estimates for Global R&D Incentive Services Market forecasted till 2028. Some of the key players profiled are KPMG…
Siveco doubles China R&D investment
On July 3, 2019, Siveco China held its half-year management meeting at the prestigious Hellas House in Shanghai, a nod to the company's continuing growth on the Belt & Road. With financial results above target, high customer satisfaction (as shown in the latest audited customer satisfaction survey) and a sales pipeline more promising than ever, the company's management board announced that shareholders have approved its request for additional investment in…
R&D Collaborative Projects by GD Rectifiers
GD Rectifiers have extensive experience in collaborative R&D projects and are proud to work with some of the UK’s pioneering power electronic companies to drive design and innovation forward.
This R&D service helps drive GD Rectifiers forward as a cutting edge manufacturer embracing fundamental technologies that support product development that contribute to next generation products throughout: renewable energy, embedded systems, smart metrering and the rail industry.
Power Assemblies, Controllers and…
Noliac is expanding the R&D team
Noliac is looking for two new colleagues for the R&D team in Prague, Czech Republic: A Precision/Fine Mechanics and an Electroengineer.
Precision/Fine Mechanics
For the R&D team in Prague, Czech Republic, Noliac is looking for a Precision/Fine mechanics to work on modifying existing products and work with developing new. Noliac requires a colleague who:
Is mechanically skilled with a focus on very small machinery.
Holds a technical high school degree or an apprenticeship…
Leiber GmbH further invests in R&D
Since February 2016, Leiber GmbH has been reinforced by Dr med vet Claudia Westfahl - a veterinarian specialized in animal nutrition - as part of the company's strategy to invest in new product developments. With the new position ‘Product Development Animal Nutrition’, Dr Westfahl is responsible for new product development in the field of functional feed ingredients for both pet as well as farm animals. After graduating at the University…
